Consensus Lazard NYSE

Stocks

LAZ

BMG540501027

Investment Management & Fund Operators

Market Closed - NYSE Other stock markets 00:00:02 10/07/2026 +04			5-day change	1st Jan Change
41.70 ^USD	+2.23%		+0.39%	+6.98%

06-29	CVC buys Italy's IRCA from Advent in second food ingredients deal this year	RE
06-26	Trump clean energy tax credit cutoff drives project rush as prices set to soar	RE

Evolution of the Average Target: Lazard

Evolution of the Target Price: Lazard

Changes in Analyst Recommendations: Lazard

778dedc8.56NFY2t1GKvpRRHEGtAr5husHohs_9No68Td8M1DPkk.1cZ9W1wPfNm8J0SQbYps0V37RrgVxrQAjaLrnqkkTSem4hEQCUQr_ZEKYg~d15fcd101cf2408006e93a3ae36a4f44

Analysts' recommendations: Lazard

07-09	Houlihan Lokey Estimates Cut by Morgan Stanley as Sponsor M&A Recovery Lags	MT
07-09	Morgan Stanley Adjusts Price Target on Lazard to $47 From $53, Maintains Underweight Rating	MT
05-04	UBS Adjusts Price Target on Lazard to $44 From $45, Maintains Neutral Rating	MT
05-04	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower	RE
05-04	Morgan Stanley Lifts Price Target on Lazard to $53 From $52, Keeps Underweight Rating	MT
04-14	Analyst recommendations: Biogen, Ford, Ge Vernova, Booking, Comcast…
04-10	BofA Securities Adjusts Price Target on Lazard to $63 From $65	MT
04-09	Wealth Brokers, Investment Banks Faced Uneven First-Quarter Activity, UBS Says	MT
04-08	UBS Adjusts Price Target on Lazard to $45 From $48, Maintains Neutral Rating	MT
04-08	Keefe, Bruyette & Woods Downgrades Lazard to Market Perform From Outperform, Adjusts Price Target to $47 From $62	MT
04-08	Analyst recommendations: Deere & Co, Verizon, Apollo Global Management, ServiceNow…
03-12	UBS Adjusts Lazard Price Target to $48 From $59, Maintains Neutral Rating	MT
01-30	UBS Adjusts Price Target on Lazard Inc to $59 From $54, Maintains Neutral Rating	MT
01-26	BofA Securities Initiates Coverage on Lazard With Buy Rating, $65 Price Target	MT
01-06	Morgan Stanley Trims Price Target on Lazard to $59 From $61, Keeps Underweight Rating	MT
24/10/25	Morgan Stanley Lifts Price Target on Lazard to $62 From $61, Keeps Underperform Rating	MT
03/10/25	BMO Capital Initiates Coverage on Lazard With Market Perform Rating, $56 Price Target	MT
18/09/25	Lazard, Inc. Appoints Geoffrey Porges as Managing Director in the Healthcare Advisory Group	CI
25/08/25	Analyst recommendations: Alaska Air, American Airlines, Dr Horton, Dollar Tree, Williams-Sonoma…
25/08/25	Keefe Bruyette & Woods Upgrades Lazard to Outperform From Market Perform, Adjusts PT to $65 From $60	MT
23/06/25	Analyst recommendations: Boston Properties, Dow, DraftKings, Estee Lauder, Jefferies…
09/04/25	UBS Adjusts Price Target on Lazard to $38 From $54, Maintains Neutral Rating	MT
03/02/25	UBS Adjusts Price Target on Lazard to $54 From $50, Maintains Neutral Rating	MT
03/01/25	Wolfe Research Downgrades Lazard to Peer Perform From Outperform	MT
20/12/24	Keefe Bruyette Woods Downgrades Lazard to Market Perform From Outperform, Adjusts Price Target to $57 From $65	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	UBS GROUP AG					+0.5%
	BLACKROCK, INC.					+26.29%
	BANK OF NEW YORK MELLON CORPORATION (THE)					+1.71%
	BROOKFIELD CORPORATION					+29.88%
	BROOKFIELD ASSET MANAGEMENT LTD.					+25.68%
	STATE STREET CORPORATION					+1.19%
	AMERIPRISE FINANCIAL, INC.					+10.8%
	3I GROUP PLC					+29.93%
	NORTHERN TRUST CORPORATION					-1.09%
	Average					+13.88%
	Weighted average by Cap.					+14.26%